Giri, Neelam

Cancer in dyskeratosis congenita

Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood

Blood disorders and treatmentsTelomeres, Telomerase, and Senescence

Cited by 478

TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita

Savage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics

Telomeres, Telomerase, and SenescenceBlood disorders and treatments

Cited by 414

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita

Alter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood

Telomeres, Telomerase, and SenescenceBlood disorders and treatments

Cited by 356

Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita

Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development

Telomeres, Telomerase, and SenescenceNuclear Structure and Function

Cited by 262

Telomere length is associated with disease severity and declines with age in dyskeratosis congenita

Alter, B. P., Rosenberg, P. S., Giri, N., Baerlocher, G. M., Lansdorp, P. M., & Savage, S. A. (2012) · Haematologica

Telomeres, Telomerase, and SenescenceBlood disorders and treatments

Cited by 238